The Study to Assess the Pharmacokinetics of Pimicotinib in Subjects With Mild and Moderate Hepatic Impairment Relative to Subjects With Normal Hepatic Function

Clinical trial NCT06562946 · COMPLETED

Trial details

NCT number: NCT06562946
Sponsor: Abbisko Therapeutics Co, Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pharmacokinetics

Start date: 2024-09-20
Primary completion: 2024-12-30
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.